What AERIE PHARMACEUTICALS INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Mcgraw Benjamin F Iii | Director | Nov 21 | Disposition to Issuer · D | −41,984 | $15.25 | −$640K | 0 |
| Gryska David W | Director | Nov 21 | Disposition to Issuer · D | −1,996 | $15.25 | −$30.4K | 0 |
| Gryska David W | Director | Nov 21 | Disposition to Issuer · D | −11,495 | $15.25 | −$175K | 0 |
| McHugh Julie | Director | Nov 21 | Disposition to Issuer · D | −16,095 | $15.25 | −$245K | 0 |
| Kannan Raj | Chief Executive Officer | Nov 21 | Disposition to Issuer · D | −215,783 | $15.25 | −$3.29M | 0 |
| Calabrese Jeffrey | Vice President of Finance | Nov 21 | Disposition to Issuer · D | −18,585 | $15.25 | −$283K | 0 |
| Croarkin Richard | Director | Nov 21 | Disposition to Issuer · D | −16,095 | $15.25 | −$245K | 0 |
| Kopczynski Casey C. | Chief Scientific Officer | Nov 21 | Disposition to Issuer · D | −280,244 | $15.25 | −$4.27M | 0 |
| McDonnell Peter J | Director | Nov 21 | Disposition to Issuer · D | −7,995 | $15.25 | −$122K | 0 |
| du Toit Michael | Director | Nov 21 | Disposition to Issuer · D | −16,095 | $15.25 | −$245K | 0 |
| Lang Peter Frederick | Chief Financial Officer | Nov 21 | Disposition to Issuer · D | −46,297 | $15.25 | −$706K | 0 |
| LaRocca John | General Counsel | Nov 21 | Disposition to Issuer · D | −53,585 | $15.25 | −$817K | 0 |
| Calabrese Jeffrey | Vice President of Finance | Nov 01 | Withheld — tax / exercise cost · F | −179 | $15.22 | −$2.72K | 18,585 |
| Calabrese Jeffrey | Vice President of Finance | Aug 14 | Withheld — tax / exercise cost · F | −265 | $11.57 | −$3.07K | 18,764 |
| LaRocca John | General Counsel | Aug 14 | Withheld — tax / exercise cost · F | −771 | $11.57 | −$8.92K | 53,585 |
| Calabrese Jeffrey | Vice President of Finance | Jul 01 | Grant / award · A | +11,276 | — | — | 19,295 |
| Calabrese Jeffrey | Vice President of Finance | Jul 01 | Withheld — tax / exercise cost · F | −266 | $8.36 | −$2.22K | 19,029 |
| Mcgraw Benjamin F Iii | Director | Jun 09 | Grant / award · A | +6,245 | — | — | 41,984 |
| Gryska David W | Director | Jun 09 | Grant / award · A | +6,245 | — | — | 11,495 |
| McHugh Julie | Director | Jun 09 | Grant / award · A | +6,245 | — | — | 16,095 |
Loading...
